Back to top

SUBSCRIPTION AGREEMENT

LLC Subscription Agreement

SUBSCRIPTION AGREEMENT | Document Parties: SMITHTOWN BANCORP INC You are currently viewing:
This LLC Subscription Agreement involves

SMITHTOWN BANCORP INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: SUBSCRIPTION AGREEMENT
Governing Law: New York     Date: 10/1/2008
Industry: Regional Banks     Law Firm: Sullivan Cromwell     Sector: Financial

SUBSCRIPTION AGREEMENT, Parties: smithtown bancorp inc
50 of the Top 250 law firms use our Products every day

 

Exhibit 10.1

 

SUBSCRIPTION AGREEMENT

 

for

 

SMITHTOWN BANCORP, INC.

A NEW YORK CORPORATION

 

COMMON SHARES, PAR VALUE $0.01 PER SHARE

 

THE COMMON SHARES (“COMMON SHARES”) REFERRED TO HEREIN HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”), AND ARE BEING OFFERED AND SOLD IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THE OFFERING OF COMMON SHARES HAS NOT BEEN REVIEWED OR APPROVED BY ANY FEDERAL OR STATE REGULATORY AUTHORITIES AND IS NOT REGISTERED UNDER APPLICABLE FEDERAL OR STATE SECURITIES LAWS.

 

A PURCHASER OF THE COMMON SHARES MUST BE PREPARED TO BEAR THE ECONOMIC RISKS OF THE INVESTMENT FOR AN INDEFINITE PERIOD OF TIME BECAUSE THE SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT AND ARE RESTRICTED AS TO TRANSFERABILITY.

 


 

TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

 

Article I

 

 

 

 

 

 

 

Purchase; Closing

 

 

 

 

 

 

1.1

Purchase

 

1

1.2

Closing

 

3

 

 

 

 

 

Article II

 

 

 

 

 

 

 

Representations and Warranties

 

 

 

 

 

 

2.1

Disclosure

 

5

2.2

Representations and Warranties of the Company

 

5

2.3

Representations and Warranties of the Investor

 

10

 

 

 

 

 

Article III

 

 

 

 

 

 

 

Covenants

 

 

 

 

 

 

3.1

Commercially Reasonable Efforts

 

13

3.2

Expenses

 

13

3.3

Publicity

 

13

3.4

Further Assurances

 

14

 

 

 

 

 

Article IV

 

 

 

 

 

 

 

Additional Agreements of the Investor

 

 

 

 

 

 

4.1

Transfer Restrictions

 

14

4.2

Legend

 

15

4.3

Registration Rights

 

16

 

 

 

 

 

Article V

 

 

 

 

 

 

 

Miscellaneous

 

 

 

 

 

 

5.1

Survival

 

25

5.2

Indemnification Generally

 

25

5.3

Interpretation

 

26

5.4

Amendment

 

26

5.5

Waiver of Conditions

 

26

5.6

Counterparts and Facsimile

 

26

5.7

Governing Law; Submission to Jurisdiction, Etc

 

26

5.8

Notices

 

27

5.9

Entire Agreement, Etc

 

27

5.10

Definitions of “Subsidiary” and “Affiliate”

 

28

5.11

Severability

 

28

5.12

No Third Party Beneficiaries

 

28

 

-i-


 

LIST OF ANNEXES

 

Annex   A

Form of Opinion of Sullivan & Cromwell LLP

 

 

Annex   B

Category of Accredited Investor

 

 

Annex   C

Federal Income Tax Backup Withholding

 

 

Annex   D

Individual Investor Questionnaire

 

-ii-


 

INDEX OF DEFINED TERMS

 

Term

 

Location of

Definition

 

 

 

Affiliate

 

5.10(b)

Agreement

 

Preamble

Applicable Time

 

4.4(g)(1)

Bankruptcy Exceptions

 

2.2(d)(1)

BHC Act

 

2.2(h)(1)

Closing

 

1.2(a)

Closing Date

 

1.2(a)

Code

 

2.3(g)

Common Shares

 

Recital A

Company

 

Preamble

Company Indemnitee

 

4.4(g)(2)

Effectiveness Deadline

 

4.3(a)(4)

ERISA

 

2.3(g)

Exchange Act

 

2.1(b)

FDIC

 

2.2(a)

Federal Reserve

 

2.2(i)(2)

Filing Deadline

 

4.3(a)(4)

GAAP

 

2.1(a)

Governmental Entities

 

2.1(a)

Hedging Transaction

 

4.1(a)

Indemnitee

 

4.4(g)(3)

Investor

 

Preamble

Investor Indemnitee

 

4.4(g)(1)

Investor Material Adverse Effect

 

2.3(b)(2)

Knowledge

 

1.3

Material Adverse Effect

 

2.1(a)

Memorandum

 

Recital B

Non-ERISA Arrangement

 

2.3(g)

Offering

 

Recital B

Payment

 

1.1(b)

Pending Offering

 

4.3(k)

Permitted Transferee

 

4.1(b)(1)

Plan

 

2.3(g)

Plan Asset Entity

 

2.3(g)

Previously Disclosed

 

2.1(b)

Purchase

 

1.1

Purchased Securities

 

Recital B

Register

 

4.4(j)

Registrable Securities

 

4.4(j)

Registration Expenses

 

4.4(j)

Representatives

 

5.2

 

-iii-


 

Rights

 

2.2(b)(1)

Rights Agreement

 

2.2(b)(1)

SEC

 

2.1(b)

SEC Reports

 

2.1(b)

Securities Act

 

2.2(a)

Selling Expenses

 

4.4(j)

Shelf Registration Statement

 

4.3(a)(2)

Significant Subsidiaries

 

2.2(a)

Significant Subsidiary

 

2.2(a)

Similar Laws

 

2.3(g)

Subscription Date

 

1.1(d)

Subsidiary

 

5.10(a)

Transaction Documents

 

Recital B

Transfer

 

4.1(a)

 

-iv-


 

Subscription Agreement , dated September 26, 2008 (together with any attachments, annexes or exhibits hereto, collectively, this “ Agreement ”), between Smithtown Bancorp, Inc., a corporation organized under the laws of the State of New York (the “ Company ”), and the Investor listed on the signature page hereof (the “ Investor ”).

 

Recitals:

 

A.   The Company . As of the date hereof, the Company has (i) 20,000,000 authorized Common Shares, par value $0.01 per share (the “ Common Shares ”), of which 9,834,477 shares are outstanding, and (ii) 100,000 authorized Preferred Shares, par value $0.01 per share, of which no shares are outstanding.

 

B.   The Issuance . The Company intends to issue Common Shares in a private placement (the “ Offering ”), and the Investor intends to purchase from the Company the number of Common Shares indicated on the signature page hereof (collectively, the “ Purchased Securities ”). For purposes of this Agreement, the term “ Transaction Documents ” refers collectively to this Agreement and any other documents, agreements and instruments delivered in connection herewith (including prior to the date hereof), in each case, as amended, modified or supplemented from time to time in accordance with their respective terms, including the Private Placement Memorandum, dated September 26, 2008, provided to the Investor (the “ Memorandum ”).

 

NOW, THEREFORE, in consideration of the premises, and of the representations, warranties, covenants and agreements set forth herein, the parties agree as follows:

 

Article I

 

Purchase; Closing

 

1.1   Purchase

 

(a)   Subscription . The Investor hereby irrevocably subscribes to purchase the number of Purchased Securities indicated on the signature page hereof for a period of 30 days from the Subscription Date (as hereinafter defined), in accordance with the terms of this Subscription Agreement (the “ Purchase ”). To effect such subscription, the Investor shall deliver an executed counterpart of this Agreement, including all Annexes hereto, to the Company or its authorized representative.

 

(b)   Payment . Together with delivery of an executed counterpart of this Agreement, including all Annexes hereto, the Investor shall deliver and pay in full the aggregate purchase price for the Purchased Securities specified on the signature page hereof (the “ Payment ”) in United States funds, to Wilmington Trust Company, the Company’s escrow agent, in the form of (1) a certified or bank cashier’s check, in immediately available funds, made payable to “Wilmington Trust Company, as Escrow Agent for Smithtown Bancorp, Inc., Account #089834-000, Attention David Young” or (2) an immediately available wire transfer to the following account: Wilmington Trust Company, ABA #031100092, Credit: Smithtown Bancorp, Inc., Escrow Account #089834-000, Attention David Young.

 


 

(c)   Acceptance . This Agreement shall be effective immediately upon acceptance by the Company of the Investor’s executed counterpart of this Agreement and shall thereupon be binding upon the Company. Such acceptance by the Company shall be evidenced only by counter-execution and delivery of this Agreement by the Company, and the Company shall have no obligation hereunder until the Company shall have executed and delivered to the Investor an executed counterpart of this Agreement. The Investor acknowledges and agrees that the Company, in its sole discretion, reserves the right to accept or reject the Purchase, in whole or in part; provided, however , that if the Company rejects the Purchase by notice to the Investor, such rejection shall serve as a termination of this Agreement, and the Investor shall have no further rights or obligations under this Agreement (but any other Transaction Document that expires by its terms as of a different date shall remain in full force and effect).

 

(d)   Termination .

 

 

(1)

This Agreement may not be terminated by the Company unless, before the Closing occurs, the Company determines in good faith that the conditions to the Closing set forth in Section 1.2(d) will not be satisfied within 10 days of the date of the Company’s acceptance of the Investor’s subscription by counter-execution and delivery of this Agreement by the Company. The Company shall deliver notice of such termination to the Investor promptly upon making such determination, and such termination shall have the effect of terminating this Agreement, effective as of the date such notice is received by the Investor in accordance with Section 5.8. Subject to the foregoing, the Company agrees to use its commercially reasonable efforts to consummate the Closing on the Closing Date (as hereinafter defined) or as soon as practicable thereafter.

 

 

(2)

This Agreement may not be terminated by the Investor at any time following the Investor’s delivery of an executed counterpart of this Agreement to the Company (even if the Company has not yet accepted or rejected the Purchase); provided, however ,   that, before the Closing has occurred, the Investor may withdraw its subscription by delivering notice of such withdrawal to the Company after a period of 15 days after the date (the “ Subscription Date ”) that is the later of (x) the first date the Investor delivers an executed counterpart of this Agreement, including all Annexes hereto, to the Company or its authorized representative and (y) the first date the Investor delivers the Payment in accordance with Section 1.1(b). Such withdrawal shall have the effect of terminating this Agreement, effective as of the date such notice is received by the Company in accordance with Section 5.8.

 

-2-


 

 

(3)

Notwithstanding the foregoing, this Agreement may be terminated by either the Company or the Investor upon written notice to the other if the Closing shall not have occurred on or before October 3, 2008.

 

 

(4)

In the event of termination of this Agreement as provided in this Section 1.1(d), (A) this Agreement shall forthwith become void, and there shall be no liability on the part of either party hereto, except that nothing herein shall relieve either party from liability for any willful breach of this Agreement, and (B) the Company shall promptly instruct its escrow agent to return any previously delivered Payment to the Investor, without interest.

 

1.2   Closing

 

(a)   On the terms and subject to the conditions set forth in this Agreement, the closing of the Purchase (the “ Closing ”) will take place at the offices of Sullivan & Cromwell LLP, 125 Broad Street, New York, New York 10004, at 10:00 a.m., New York City time, on September 29, 2008 or as soon as practicable thereafter, or at such other place, time and date as shall be agreed between the Company and the Investor. The time and date on which the Closing occurs is referred to in this Agreement as the “ Closing Date .”

 

(b)   At the Closing, the Company will deliver to the Investor the Purchased Securities, as evidenced by one or more certificates dated the Closing Date and bearing appropriate legends as hereinafter provided for, registered on the books and records of the Company in such Investor’s name.

 

(c)   The obligation of the Investor to consummate the Closing is also subject to the fulfillment (or waiver by the Investor) at or prior to the Closing of each of the following conditions:

 

 

(1)

(A) the representations and warranties of the Company set forth in this Agreement shall be true and correct as though made on and as of the Closing Date (other than representations and warranties that by their terms speak as of another date, which representations and warranties shall be true and correct as of such date), except to the extent that the failure of such representations and warranties to be so true and correct (without giving effect to any qualifiers or exceptions relating to materiality or Material Adverse Effect (as hereinafter defined)), individually or in the aggregate, does not have and would not reasonably be expected to have a Material Adverse Effect and (B) the Company shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing;

 

-3-


 

 

(2)

the Investor shall have received from Sullivan & Cromwell LLP a legal opinion in the form attached hereto as Annex   A , addressed to the Investor, dated as of the Closing Date; and

 

 

(3)

the Investor shall have received a certificate dated as of the Closing Date signed on behalf of the Company by a senior officer of the Company certifying compliance with Section 1.2(c)(1).

 

(d)   The obligation of the Company to consummate the Closing is also subject to the fulfillment (or waiver by the Company) at or prior to the Closing of each of the following conditions:

 

 

(1)

(A) the representations and warranties of the Investor set forth in this Agreement shall be true and correct as though made on and as of the Closing Date (other than representations and warranties that by their terms speak as of another date, which representations and warranties shall be true and correct as of such date), except to the extent that the failure of such representations and warranties to be so true and correct (without giving effect to any qualifiers or exceptions relating to materiality or Material Adverse Effect (as hereinafter defined)), individually or in the aggregate, does not have and would not reasonably be expected to have a Material Adverse Effect and (B) the Investor shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing;

 

 

(2)

the Company shall have received from Sullivan & Cromwell LLP a legal opinion substantially in the form attached hereto as Annex   A , addressed to the Company, dated as of the Closing Date; and

 

 

(3)

the Company shall have received a certificate dated as of the Closing Date signed by the Investor or an authorized representative of the Investor certifying compliance with Section 1.2(d)(1).

 

-4-


 

Article II

 

Representations and Warranties

 

2.1   Disclosure .

 

(a)   Material Adverse Effect ” means a material adverse effect on (1) the business, results of operation or financial condition of the Company and its subsidiaries taken as a whole; provided that Material Adverse Effect shall not be deemed to include the effects of (A) any facts, circumstances, events, changes or occurrences generally affecting businesses and industries in which the Company operates, companies engaged in such businesses or industries or the economy, or the financial or securities markets and credit markets in the United States or elsewhere in the world, including effects on such businesses, industries, economy or markets resulting from any regulatory or political conditions or developments, or any outbreak or escalation of hostilities, declared or undeclared acts of war, terrorism, or work stoppages, (B) changes or proposed changes in generally accepted accounting principles in the United States (“ GAAP ”) or regulatory accounting requirements applicable to depository institutions and their holding companies generally (or authoritative interpretations thereof), (C) changes or proposed changes in banking and other laws of general applicability or related policies or interpretations of all United States governmental or regulatory authorities (collectively, “ Governmental Entities ”), or (D) changes in the market price or trading volume of Common Shares (it being understood and agreed that the exception set forth in this clause (D) does not apply to the underlying reason giving rise to or contributing to any such change), or (2) the ability of the Company timely to consummate the Purchase and the other transactions contemplated by the Transaction Documents.

 

(b)   Previously Disclosed ” means (1) information contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, or its other reports and forms filed with the Securities and Exchange Commission (the “ SEC ”) under Sections 13(a), 14(a) or 15(d) of the Securities Exchange Act of 1934 (the “ Exchange Act ”) on or after January 1, 2008 (the “ SEC Reports ”) and prior to the execution and delivery of this Agreement, and (2) information contained in the Memorandum.

 

(c)   Each party acknowledges that it is not relying upon any representation or warranty not set forth in the Transaction Documents. The Investor acknowledges that it has conducted a review and analysis of the business, assets, condition, operations and prospects of the Company and its subsidiaries, together with the representations and warranties of the Company set forth in the Transaction Documents, that the Investor considers sufficient for purposes of the Purchase.

 

2.2   Representations and Warranties of the Company . Except as Previously Disclosed, the Company represents and warrants to the Investor that as of the date hereof and the Closing Date (or such other date specified herein):

 

(a)   Organization, Authority and Significant Subsidiaries . The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of New York, with corporate power and authority to own its properties and conduct its business in all material respects as currently conducted, and, except as has not had or would not reasonably be expected to have a Material Adverse Effect, has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification; and each Subsidiary (as defined in Section 5.10(a)) of the Company that is a “significant subsidiary” within the meaning of Rule 1-01(w) of Regulation S-X under the Securities Act of 1933, as amended (the “ Securities Act ”) (each, a “ Significant Subsidiary ” and, collectively, the “ Significant Subsidiaries ”) has been duly organized and is validly existing in good standing under the laws of its jurisdiction of organization. The Company’s principal depository institution Subsidiary is duly organized and validly existing as a New York State chartered bank, and its deposit accounts are insured up to applicable limits by the Federal Deposit Insurance Corporation (the “ FDIC ”).

 

-5-


 

(b)   Capitalization .

 

 

(1)

As of the date hereof, the authorized and outstanding capital stock of the Company is as set forth in Recital A.

 

 

(2)

All of the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and were not issued in violation of any preemptive rights, resale rights, rights of first refusal or similar rights.

 

 

(3)

All of the outstanding shares of capital stock of each Significant Subsidiary have been duly and validly authorized and issued, are fully paid and non-assessable and were not issued in violation of any preemptive rights, resale rights, rights of first refusal or similar rights, and are owned directly or indirectly by the Company, free and clear of all security interests, liens, encumbrances, equities or claims.

 

 

(4)

Except for the Rights (as hereinafter defined) issued pursuant to the Rights Agreement (as hereinafter defined) and awards of restricted Common Shares pursuant to the Company’s equity compensation and/or employee stock purchase plans, there are no options, warrants or other rights, agreements, arrangements or commitments to which the Company is a party or by which the Company is bound relating to the issued or unissued Common Shares of the Company. For purposes of this Agreement, “ Rights ” means the rights to purchase Common Shares of the Company issued pursuant to the Rights Agreement, and “ Rights Agreement ” means the Shareholder Protection Rights Agreement, dated as of September 23, 1997 and last amended as of February 6, 2008, by and between the Company and Mellon Investor Services LLC, setting forth the rights of the holders of Rights.

 

(c)   The Purchased Securities . The Purchased Securities will be, as of the Closing Date, duly authorized by all necessary corporate action on the part of the Company and, when issued and delivered as provided in this Agreement, will be duly and validly issued, fully paid and non-assessable, and the issuance thereof will not be subject to any preemptive or similar rights.

 

-6-


 

(d)   Authorization and Enforceability of Transaction Documents .

 

 

(1)

The Company has the corporate power and authority to execute and deliver the Transaction Documents to which it is a party and to carry out its obligations hereunder and thereunder (which includes the issuance of the Purchased Securities). The execution, delivery and performance by the Company of the Transaction Documents to which it is a party and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company and its shareholders, and no further approval or authorization is required on the part of the Company or its shareholders. The Transaction Documents to which the Company is a party are or will be valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms, except as the same may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and general equitable principles, regardless of whether such enforceability is considered in a proceeding at law or in equity (“ Bankruptcy Exceptions ”).

 

 

(2)

The execution, delivery and performance by the Company of the Transaction Documents to which it is a party, the consummation of the transactions contemplated hereby and thereby and compliance by the Company with any of the provisions hereof and thereof, will not violate, conflict with, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, result in the termination of or accelerate the performance required by, or result in a right of termination or acceleration of, or result in the creation of, any lien, security interest, charge or encumbrance upon any of the properties or assets of the Company or any Significant Subsidiary under any of the terms, conditions or provisions of (A) the certificate of incorporation, by-laws or other organizational document of the Company or any Significant Subsidiary or (B) any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Company or any Significant Subsidiary is a party or by which it or any Significant Subsidiary may be bound, or to which the Company or any Significant Subsidiary or any of the properties or assets of the Company or any Significant Subsidiary may be subject, or (C) subject to compliance with the statutes and regulations referred to in Section 2.2(d)(3), violate any statute, rule or regulation or any judgment, ruling, order, writ, injunction or decree applicable to the Company or any Significant Subsidiary or any of their respective properties or assets except, in the case of clauses (B) and (C), for those occurrences that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect.

 

 

(3)

Other than in connection or in compliance with the provisions of the Securities Act and the securities or “blue sky” laws of the various states, to the Company’s Knowledge without inquiry, no notice to, filing with, exemption or review by, or authorization, consent or approval of, any Governmental Entity is required to be made or obtained by the Company in connection with the Purchase and the other transactions contemplated by the Transaction Documents.

 

-7-


 

(e)   Company Financial Statements . The consolidated financial statements of the Company and its subsidiaries (including the related notes and supporting schedules) contained in the SEC Reports present fairly in all material respects the consolidated financial position of the Company and its consolidated subsidiaries as of the dates indicated therein and the consolidated results of their operations for the periods specified therein; and except as stated therein, such financial statements were prepared in conformity with GAAP applied on a consistent basis.

 

(f)   No Material Adverse Effect . Since June 30, 2008, no fact, circumstance, event, change, occurrence, condition or development has occurred that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.

 

(g)   Proceedings . As of the date of this Agreement, there is no litigation or similar proceeding or governmental proceeding pending or, to the Company’s Knowledge, threatened to which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its subsidiaries is the subject that the Company’s management believes, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.

 

(h)   Compliance with Laws; Permits .

 

 

(1)

The Company is a bank holding company registered under the Bank Holding Company Act of 1956 (the “ BHC Act ”); the Company and each of its subsidiaries have conducted their businesses in compliance with all applicable federal, state and foreign laws, orders, judgments, decrees, rules, regulations and applicable stock exchange requirements, including all laws and regulations restricting activities of bank holding companies and banking organizations, except for any noncompliance that, individually or in the aggregate, has not had and would not be reasonably expected to have a Material Adverse Effect.

 

 

(2)

The Company and each Subsidiary have all permits, licenses, authorizations, orders and approvals of, and have made all filings, applications and registrations with, any Governmental Entities that are required in order to carry on their business as presently conducted, except where the failure to have such permits, licenses, authorizations, orders and approvals or the failure to make such filings, applications and registrations, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect; and all such permits, licenses, certificates of authority, orders and approvals are in full force and effect and, to the Knowledge of the Company without inquiry, no suspension or cancellation of any of them is threatened, and all such filings, applications and registrations are current, except where such absences, suspensions or cancellations, individually or in the aggregate, have not had or would not reasonably be expected to have a Material Adverse Effect.

 

-8-


 

(i)   Reports .

 

 

(1)

Since December 31, 2006, the Company has timely filed all documents required to be filed with the SEC pursuant to Sections 13(a), 14(a) and 15(d) of the Exchange Act.

 

 

(2)

Since December 31, 2006, the Company and each Subsidiary have filed all material reports, registrations and statements, together with any required amendments thereto, that it was required to file with the Board of Governors of the Federal Reserve System (the “ Federal Reserve ”), the FDIC, the New York State Banking Department and any other applicable federal or state securities or banking authorities, except where the failure to file any such report, registration or statement, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect. As of their respective dates, each of the foregoing reports complied with all applicable rules and regulations promulgated by the Federal Reserve, the FDIC, the New York State Banking Department and any other applicable foreign, federal or state securities or banking authorities, as the case may be, except for any failures that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect.

 

(j)   Memorandum . The Memorandum does not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

 

(k)   No General Solicitation or General Advertising . Neither the Company nor any person acting on its behalf has engaged or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with any offer or sale of the Purchased Securities.

 

(l)   No Integration . The Company has not, directly or indirectly, solicited any offer to buy or offer to sell any Common Shares in a manner that would require the registration of the Purchased Securities pursuant to the Securities Act and has no present intention to solicit any offer to buy or offer to sell any Purchased Securities or any other securities of the Company other than pursuant to (1) this form of Subscription Agreement, (2) pursuant to a registered public offering of the Purchased Securities and other Common Shares offered and sold in the Offering as contemplated by this form of Subscription Agreement or (3) pursuant to the Company’s equity compensation and/or employee stock purchase plans.

 

-9-


 

2.3   Representations and Warranties of the Investor . The Investor hereby represents and warrants to the Company that as of the date hereof and the Closing Date:

 

(a)   Organization and Authority . The Investor (1) has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its organization, with the requisite power and authority to own its properties and conduct its business as currently conducted or (2) is a natural person.

 

(b)   Authorization and Enforceability of Transaction Documents .

 

 

(1)

The Investor has the requisite power and authority to execute and deliver the Transaction Documents to which it is a party and to carry out its obligations hereunder and thereunder. The execution, delivery and performance by the Investor of the Transaction Documents to which it is a party and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Investor, and no further approval or authorization is required on the part of the Investor. The Transaction Documents to which the Investor is a party are or will be valid and binding obligations of the Investor enforceable against the Investor in accordance with their respective terms, except as the same may be limited by Bankruptcy Exceptions.

 

 

(2)

The execution, delivery and performance by the Investor of the Transaction Documents to which it is a party, the consummation of the transactions contemplated hereby and thereby and compliance by the Investor with any of the provisions hereof and thereof, will not (A) violate, conflict with, or result in a breach of any provision of or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, accelerate the performance required by, result in a right of termination or acceleration of or result in the creation of, any lien, security interest, charge or encumbrance upon any of the properties or assets of such Investor under any of the terms, conditions or provisions of (i) its organizational documents or (ii) any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Investor is a party or by which it may be bound, or to which the Investor or any of the properties or assets of the Investor may be subject, or (B) subject to compliance with the statutes and regulations referred to in Section 2.3(b)(3), violate any statute, rule or regulation or any judgment, ruling, order, writ, injunction or decree applicable to the Investor or any of its properties or assets except, in the case of clauses (A)(ii) and (B), for those occurrences that, individually or in the aggregate, have not had and would not reasonably be expected to have an Investor Material Adverse Effect. “ Investor Material Adverse Effect ” means a material adverse effect on the ability of the Investor timely to consummate the Purchase and the other transactions contemplated by this Agreement.

 

-10-


 

 

(3)

Other than in connection or in compliance with the provisions of the Securities Act and the securities or “blue sky” laws of the various states, to the Investor’s Knowledge without inquiry, no notice to, filing with, exemption or review by, or authorization, consent or approval of, any Governmental Entity is required to be made or obtained by the Investor in connection with


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more